CHLD
CHANGE OF OWNER RECEIVED FROM IB
12/03/2026
Voltar para busca
Dado oficial do USPTO
CELLISTIC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
42
Data de depósito
10/07/2023
Data de registro
07/01/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/01/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
98
Localização do titular
BE
Examinador
GIBBONS, BRIAN R
Unidade examinadora
L60
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the following: a purple circle made of lines with a white diamond in the center, and the black wording CELLISTIC.
Titulares e representantes
Titulares
Celyntra Therapeutics SA
Cellistic SA
Ncardia B.V.
Representantes
Cellistic SA
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Laboratory research in the field of biopharmaceuticals; laboratory research in the field of biotechnology; biotechnology research and testing; development of new technology for others in the field of biotechnology; scientific research on stem cells; scientific research on the production and differentiation of pluripotent stem cells; research and development in the field of stem cellscell therapy and biotechnology; pharmaceutical research and development; scientific laboratory services; providing information with respect to scientific research in the field of stem cellscell and gene therapy and biotechnology; product research and development for the pharmaceutical industry; technological consultancy in the field of biotechnology; technological consultancy in the field of biotechnology for the pharmaceutical industry; new biopharmaceutical product design services; new product design services for the pharmaceutical industry; industrial analysis of pharmaceuticals; pharmaceutical research services; biopharmaceutical research and development; research and development of new biopharmaceutical products for others; biopharmaceuticals product development consultation; scientific research consultancy; scientific research consultancy in the field of pharmaceuticals; none of the foregoing for design and development of products in the field of computer hardware
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
26/07/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/07/2025
FIMP
FINAL DISPOSITION PROCESSED
04/07/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/04/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/02/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/01/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
15/01/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/01/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
07/01/2025
PUBO
PUBLISHED FOR OPPOSITION
19/11/2024
NPUB
NOTICE OF PUBLICATION
13/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/10/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
11/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/10/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/10/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/08/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/08/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/08/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/08/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/08/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/07/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/07/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/07/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/07/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/07/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/07/2024
RFNT
REFUSAL PROCESSED BY IB
08/05/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/04/2024
RFRR
REFUSAL PROCESSED BY MPU
11/04/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
24/03/2024
CNRT
NON-FINAL ACTION WRITTEN
23/03/2024
DOCK
ASSIGNED TO EXAMINER
19/03/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/12/2023
MAFR
APPLICATION FILING RECEIPT MAILED
22/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/08/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
17/08/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CELLISTIC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.